Ewing sarcoma is characteristic with a recurrent chromosomal translocation and the EWS-FLI fusion may provide a new way in the targeted therapy of Ewing sarcoma (Cidre-Aranaz and Alonso, 2015). Here, FLII is linked to Ewing sarcoma.